Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Longboard Pharmaceuticals (LBPH) News Today

Longboard Pharmaceuticals logo

LBPH Latest News

H Lundbeck A/S (HLUNAC.XD)
H. Lundbeck A/S (HLUN-A.CO)
Longboard Pharmaceuticals Advances Neurological Treatments
Longboard Pharmaceuticals granted Orphan Drug Designation for bexicaserin
Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal
Get Longboard Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter.

LBPH Media Mentions By Week

LBPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LBPH
News Sentiment

0.00

0.91

Average
Medical
News Sentiment

LBPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LBPH Articles
This Week

0

4

LBPH Articles
Average Week

Get Longboard Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LBPH) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners